New: NCI-funded clinical trial search
Mednet Logo

Can the elective target volume in nasopharyngeal cancer, as specified in RTOG 0615, be reduced if OARs do not meet constraints?

Conversely, should OARs be kept within contraints if it requires dose compromise on these high risk CTV structures?
3 Answers
Mednet MemberInvited Expert
Radiation Oncology · Memorial Sloan Kettering Cancer Center
Answered on

Always protect the brainstem, spinal cord, and chiasm and by that, there will be some compromise of the target. One should not change the target.

Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

No. I do not reduce the PTVs. I exceed the OAR dose constraints if necessary.

Mednet MemberInvited Expert
Radiation Oncology · Northwestern University
Answered on

I agree with with @Dr. First Last.